Canada - engelsk - Health Canada

novo nordisk canada inc - somapacitan - solution - 5mg - somapacitan 5mg

Canada - engelsk - Health Canada

novo nordisk canada inc - somapacitan - solution - 10mg - somapacitan 10mg

Canada - engelsk - Health Canada

novo nordisk canada inc - somapacitan - solution - 15mg - somapacitan 15mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - somapacitan, quantity: 6.7 mg/ml - injection, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; poloxamer; histidine; phenol; hydrochloric acid - sogroya is indicated for,? the replacement of endogenous growth hormone (gh) in paediatric patients aged 2 years and above with growth failure due to growth hormone deficiency (ghd).,? the replacement of endogenous growth hormone (gh) in adults with growth hormone deficiency (aghd).

Den europeiske union - islandsk - EMA (European Medicines Agency)

novo nordisk a/s - somapacitan - vöxtur - hinsveiflur og heilahimnubólur og hliðstæður - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

polfarmex s.a. - tramadoli hydrochloridum + paracetamolum + cellulosi pulvis - tabletki powlekane - 37,5 mg + 325 mg

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

polfarmex s.a. - paracetamolum + tramadoli hydrochloridum - tabletki powlekane - 650 mg + 75 mg

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

symphar sp. z o.o. - indapamidum - tabletka o przedłużonym uwalnianiu - 1,5 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

novo nordisk a/s - somapacitan - vekst - hypofysiske og hypotalamiske hormoner og analoger - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

teva sante - pantoprazole - comprimé - 20 mg - composition pour un comprimé > pantoprazole : 20 mg . sous forme de : pantoprazole sodique sesquihydraté 22,6 mg - inhibiteurs de la pompe a protons